Reichen J, Hoilien C, Kirshenbaum G R
Experientia. 1986 Aug 15;42(8):942-5. doi: 10.1007/BF01941772.
Cimetidine inhibits oxidative drug metabolism; it is not known whether this drug alters the catabolic fate of hepatic heme. We therefore investigated hepatic heme turnover both by a 14CO breath test and directly by labeling the heme pool. Neither acute (150 mg/kg i.p.) nor chronic (150 mg/kg i.p. bid for 3 days) cimetidine administration significantly affected hepatic heme turnover. Chronic, but not acute, cimetidine significantly (p less than 0.025) increased heme oxygenase activity. Cimetidine inhibited heme oxygenase activity in vitro at concentrations achieved in vivo.
西咪替丁抑制药物的氧化代谢;尚不清楚该药物是否会改变肝脏血红素的分解代谢命运。因此,我们通过14C呼气试验以及直接标记血红素池来研究肝脏血红素的周转情况。无论是急性给予西咪替丁(150mg/kg腹腔注射)还是慢性给予(150mg/kg腹腔注射,每日两次,共3天),均未对肝脏血红素周转产生显著影响。慢性而非急性给予西咪替丁可显著(p<0.025)提高血红素加氧酶活性。在体内达到的浓度下,西咪替丁在体外可抑制血红素加氧酶活性。